FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

WEDNESDAY, Sept. 24, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) f